Patents by Inventor Caidian WANG

Caidian WANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GLP-1 AGONIST POLYPEPTIDE COMPOUND AND SALT THEREOF, SYNTHESIS METHOD THEREFOR AND USE THEREOF
    Publication number: 20230220033
    Abstract: The disclosure provides a GLP-1 agonist polypeptide compound having an amino acid sequence: H Xaa1EGTFTSDVSSYLE Xaa2QAA Xaa3EFIAWLVRGRG (SEQ ID NO: 1). The C-terminal amino acid of the polypeptide compound is a carboxyl or the carboxyl is amidated. Xaa1 and Xaa2 are the same or different; R1 is: a straight-chain or branched-chain alkyl containing 2-6 carbon atoms, R2 is: H or CH3, X is: O, S or N—CH3, in the formula, R1 and R2 alkyl is optionally substituted by 1-6 halogen atoms.
    Type: Application
    Filed: August 17, 2022
    Publication date: July 13, 2023
    Inventors: Chengqing ZHAO, Guoqiang SHI, Shunzi LI, Caidian WANG
  • GIP AND GLP-1 DUAL AGONIST POLYPEPTIDE COMPOUND, PHARMACEUTICALLY ACCEPTABLE SALT AND APPLICATION THEREOF
    Publication number: 20220251163
    Abstract: A GIP and GLP-1 dual agonist polypeptide compound, having an amino acid sequence as follows: (SEQ?ID?NO:?1) YXaa1EGTFTSDYSIXaa2LDKIAQXaa3AFVQWLIAGGPSSGAPPPS, and a C-terminal amino acid of polypeptide compound being amidated as a C-terminal primary amide.
    Type: Application
    Filed: April 8, 2022
    Publication date: August 11, 2022
    Inventors: Chengqing ZHAO, Haitao GU, Guoqiang SHI, Jianjun JIANG, Caidian WANG